Image source: Pfizer. What: Shares of Irish-based pharmaceutical giant Allergan (NYSE: AGN), which is perhaps best known for its dermatology and aesthetic product line -- which includes Botox -- shed 19% of their value in April, according to data from S&P Global Market Intelligence. The reason behind the decline can be found in a bevy of new U.S.